Supplementary Table S2 from A Tumor-suppressive Molecular Axis EP300/circRERE/miR-6837-3p/MAVS Activates Type I IFN Pathway and Antitumor Immunity to Suppress Colorectal Cancer di Nan Ding (15321526)

Soggetti:

Supplementary Table S1-19 from Germline Cancer Gene Expression Quantitative Trait Loci Are Associated with Local and Global Tumor Mutations di Yuxi Liu (15293121)

Soggetti:

Table S7 from Shared Cancer Dataset Analysis Identifies and Predicts the Quantitative Effects of Pan-Cancer Somatic Driver Variants di Jakob Landau (14962529)

Soggetti:

Table S5 from The RNA m⁶A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression di Yun-Guang Hong (14960966)

Soggetti:

Table S3 from The RNA m⁶A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression di Yun-Guang Hong (14960966)

Soggetti:

Table S2 from The RNA m⁶A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression di Yun-Guang Hong (14960966)

Soggetti:

Table S4 from The RNA m⁶A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression di Yun-Guang Hong (14960966)

Soggetti:

Table S1 from The RNA m⁶A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression di Yun-Guang Hong (14960966)

Soggetti:

Supplementary Figure from Mutated HRAS Activates YAP1–AXL Signaling to Drive Metastasis of Head and Neck Cancer di Sankar Jagadeeshan (15112900)

Soggetti:

Supplementary Tables 1 from Proteostasis Modulation in Germline Missense von Hippel Lindau Disease di Prashant Chittiboina (15367044)

Soggetti:

Supplementary table S5 from HDAC5 Loss Enhances Phospholipid-Derived Arachidonic Acid Generation and Confers Sensitivity to cPLA2 Inhibition in Pancreatic Cancer di Penglin Pan (14959703)

Soggetti:

Table S6 from The RNA m⁶A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression di Yun-Guang Hong (14960966)

Soggetti:

Supplementary Data S2 from A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States di Namhee Kim (14963603)

Soggetti:

Supplementary Data S1 from A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States di Namhee Kim (14963603)

Soggetti:

Supplementary Table 1 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants di Dhruv Chachad (14954640)

Soggetti:

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification di Robert L. Hollis (15034814)

Soggetti:

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification di Robert L. Hollis (15034814)

Soggetti:

Figure S3 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans di Yuanqing Ma (15052437)

Soggetti:

Supplementary Table 4 from Unique Transcriptional Profiles Underlie Osteosarcomagenesis Driven by Different p53 Mutants di Dhruv Chachad (14954640)

Soggetti:

Figure S4 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans di Yuanqing Ma (15052437)

Soggetti: